CAP-CD56+CD271+ BMSCs Exos-PVA/SA hydrogel
1 paper1 finding
- 1 lab in 1 country
- Funders: Education Department of Hunan Province and 2 more
- Animals1
Outcomes
1Senescence markers
downin humans1
1 study
Senescence markers
downin humans1
CAP-CD56+CD271+ BMSCs Exos-PVA/SA hydrogel decreases senescence markers in humans.
“Implantation of the integrated CAP-Exos-PVA/SA system markedly improved osteoarthritis cartilage structure, increased matrix deposition, and suppressed the expression of matrix metalloproteinase-13 (MMP-13) and senescence markers (p16/p21/p53).”
Animalsosteoarthritis
Bioactive materials6 Nov 2025